Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)
复制标题
DOI：
10.1007/s00432-018-2795-1
复制
发表时间：
2019-03-01
影响因子：
3.6
通讯作者：
Zhou, Zongguang
中科院分区：
文献类型：
--
作者：
Xu, Jianmin;Fan, Jia;Zhou, Zongguang
肝脏是结直肠癌血行转移最常见的解剖部位，结直肠肝转移是结直肠癌治疗中最困难、最具挑战性的点之一。为了提高中国的诊断和综合治疗水平，自2008年以来，《指南》进行了多次编辑和修订，包括总体评价、个性化治疗目标和综合治疗，以防止肝转移的发生，提高肝转移的切除率和生存率。修订后的指南包括诊断与随访、预防、MDT效果、手术与局部消融治疗、新辅助与辅助治疗、综合治疗等内容，经验先进、成果最新、内容详细、可操作性强。
The liver is the most common anatomical site for hematogenous metastases of colorectal cancer, and colorectal liver metastases is one of the most difficult and challenging points in the treatment of colorectal cancer. To improve the diagnosis and comprehensive treatment in China, the Guidelines have been edited and revised several times since 2008, including the overall evaluation, personalized treatment goals and comprehensive treatments, to prevent the occurrence of liver metastases, improve the resection rate of liver metastases and survival. The revised Guideline includes the diagnosis and follow-up, prevention, MDT effect, surgery and local ablative treatment, neoadjuvant and adjuvant therapy, and comprehensive treatment, and with advanced experience, latest results, detailed content, and strong operability.